Chief Scientific OfficerCerus CorporationConcord, California, United States
PB1055 - Retention of critical hemostatic functions of amotosalen-UVA Pathogen-Reduced Cryoprecipitated Fibrinogen Complex under variable shear flow rates
Tuesday, June 25, 202413:45 – 14:45 ICT